@article{63e2a4ed25e0425788fd4f5622b5d86d,
title = "Telemedicine as an Untapped Opportunity for Parkinson's Nurses Training in Personalized Care Approaches",
abstract = "(1) Background: Parkinson nurses (PN) take over important functions in the telemedical care of person's with Parkinson's disease (PwPs). This requires special competencies that have so far been largely unexplored. The aim of the article is to identify competencies of PN operating in a personalized care model. (2) Methods: This study employed a qualitative approach. Based on the competency framework for telenursing, PN were asked about their competencies using a qualitative online survey. (3) Results: The results show that PN need competencies on a personal and organizational level, as well as in the relationship with PwPs. PN have developed these skills through professional exchange, training, and personal experience. In addition, both hindering and beneficial factors for the development of competencies could be identified. (4) Conclusions: Competency development for telemedical care is complex and must be designed and promoted in a targeted manner.",
keywords = "Parkinson's disease, nursing training, telenursing, telemedicine, Parkinson nurse, personalized care, competency development",
author = "{van Munster}, M. and J. Stumpel and T. Clemens and K. Czabanowska and D.J. Pedrosa and T.A. Mestre and {iCare-PD consortium}",
note = "Funding Information: Funding: This research was funded as part of the research project “iCARE-PD”. This is an EU Joint Programme—Neurodegenerative Disease Research (JPND) project (Reference Number: HESOCARE-329-073). The project is supported through the following funding organisations under the aegis of JPND—www.jpnd.eu (accessed on 1st July 2022): Canada—Canadian Institutes of Health Research; Czech Republik—Ministry of Education, Youth and Sport of the Czech Republic; France—Agence National de la Recherche; Germany—Bundesministerium f{\"u}r Bildung und Forschung; Spain—National Institute of Health Carlos III; United Kingdom—Medical Research Council. M.v.M. and J.S. are funded by the aforementioned research project “iCARE-PD”. Funding Information: This research was funded as part of the research project “iCARE-PD”. This is an EU Joint Programme—Neurodegenerative Disease Research (JPND) project (Reference Number: HESOCARE-329-073). The project is supported through the following funding organisations under the aegis of JPND—www.jpnd.eu (accessed on 1st July 2022): Canada—Canadian Institutes of Health Research; Czech Republik—Ministry of Education, Youth and Sport of the Czech Republic; France—Agence National de la Recherche; Germany—Bundesministerium f{\"u}r Bildung und Forschung; Spain—National Institute of Health Carlos III; United Kingdom—Medical Research Council. M.v.M. and J.S. are funded by the aforementioned research project “iCARE-PD”. Funding Information: Conflicts of Interest: M.v.M. declares no C.o.I.; J.S. declares no C.o.I.; T.C. declares no C.o.I; K.C. declares no C.o.I.; D.P. declares no C.o.I.; T.A.M. has received personal compensation for serving as a Consultant for CHDI, Sunovion, Valeo Pharma, Roche, Biogen and nQ medical. He has received personal compensation serving on a Speakers Bureau for AbbVie and Valeo Pharma. He has received research support from the Canadian Institutes of Health Research, the Ontario Research Fund, the Michael J Fox Foundation, Parkinson Canada, the University of Ottawa/Parkinson Research Consortium, and the Weston Brain Foundation. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2022",
month = jul,
day = "1",
doi = "10.3390/jpm12071057",
language = "English",
volume = "12",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",
}